Evaluation of the antibacterial activity of poly-(d,l-lactide-co-glycolide) nanoparticles containing violacein

Journal of Nanoparticle Research

Volumn 13, Issue 1, 2011, Pages 355-363

  Martins, D ^a   Costa, F T M ^a   Brocchi, M ^a   Duran N ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b NONE

Author keywords

Antibacterial activity; Antibiotics; Encapsulation; Polymeric nanoparticles; Solubility; Staphylococcus aureus; Violacein

Indexed keywords

ANTI-BACTERIAL ACTIVITY; AVERAGE DIAMETER; BIOLOGICAL ACTIVITIES; D , L-LACTIDE; DRUG LOADING; DRUG-LOADING EFFICIENCY; GLYCOLIDE; IN-VITRO; MINIMUM INHIBITORY CONCENTRATION; NANOPRECIPITATION METHOD; OUTER SURFACE; POLYMERIC NANOPARTICLES; RESISTANT STAPHYLOCOCCUS AUREUS; SALMONELLA ENTERICA; STAPHYLOCOCCUS AUREUS; SUSTAINED RELEASE; VIOLACEIN;

ANTIBIOTICS; BIOMATERIALS; ESCHERICHIA COLI; ORGANIC POLYMERS; POLYMERS; SOLUBILITY; ZETA POTENTIAL;

NANOPARTICLES;

ANTIBIOTIC AGENT; NANOPARTICLE; POLYGLACTIN; UNCLASSIFIED DRUG; VIOLACEIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG RELEASE; DRUG SOLUBILITY; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; IN VITRO STUDY; KINETICS; MINIMUM INHIBITORY CONCENTRATION; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PRECIPITATION; PRIORITY JOURNAL; SALMONELLA ENTERICA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; ZETA POTENTIAL;

EID: 79551580345     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-010-0037-9     Document Type: Article

References (34)

1. N Bromberg GZ Justo M Haun N Durán CV Ferreira 2005 Violacein cytotoxicity on human blood lymphocytes and effect on phosphatases J Enzym Inhib Med Chem 20 449 454 1:CAS:528:DC%2BD2MXht1eltL%2FI 10.1080/14756360500273052
2. N Bromberg JL Dreyfuss CV Regatieri MV Palladino N Durán HB Nader M Haun GZ Justo 2010 Growth inhibition and pro-apoptotic activity of violacein in Ehrlich ascites tumor Chem Biol Interact 186 43 52 1:CAS:528: DC%2BC3cXmsVGnur0%3D 10.1016/j.cbi.2010.04.016
3. CLSI-Committee for Clinical Laboratory Standards (2003) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th edn. CLSI, Wayne, USA
4. F Cui K Shi L Zhang A Tao Y Kawashima 2006 Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation J Control Release 114 242 250 1:CAS:528:DC%2BD28XovF2ksbk%3D 10.1016/j.jconrel.2006.05.013
5. GG Cury C Mobilon EG Stehling M Lancellotti MC Ramos R Martinez M Brocchi WD Silveira 2009 Molecular typing of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated in two metropolitan areas of São Paulo State, Southeast Brazil Braz J Infect Dis 13 165 169 10.1590/S1413- 86702009000300002
6. DD De Carvalho FT Costa N Duran M Haun 2006 Cytotoxic activity of violacein in human colon cancer cells Toxicol In Vitro 20 1514 1521 10.1016/j.tiv.2006.06.007
7. AO De Souza DCG Aily DN Sato N Durán 1999 Atividade da violaceina in vitro sobre o Mycobacterium tuberculosis H37RA Rev Inst Adolfo Lutz 58 59 62
8. RH Demling B Waterhouse 2007 The increasing problem of wound bacterial burden and infection in acute and chronic soft-tissue wounds caused by methicillin-resistant Staphylococcus aureus J Burns Wounds 7 89 98
9. N Durán CF Menck 2001 Chromobacterium violaceum: a review of pharmacological and industrial perspectives Crit Rev Microbiol 27 201 222 10.1080/20014091096747
10. N Durán GZ Justo PS Melo MBM De Azevedo ARMMS Brito ABA Almeida M Haun 2003 Evaluation of the antiulcerogenic activity of violacein and its modulation by the inclusion complexation with beta-cyclodextrin Can J Physiol Pharmacol 81 387 396 10.1139/y03-033
11. N Durán GZ Justo CV Ferreira PS Melo L Cordi D Martins 2007 Violacein: properties and biological activities Biotechnol Appl Biochem 48 127 133 10.1042/BA20070115
12. N Durán PD Marcato GD De Souza OL Alves E Esposito 2007 Antibacterial effect of silver nanoparticles produced by fungal process on textile fabrics and their effluent treatment J Biomed Nanotechnol 3 203 208 10.1166/jbn.2007.022
13. N Durán PD Marcato CMS Buffo MMM De Azevedo E Esposito 2007 Poly (epsilon-caprolactone)/propolis extract: microencapsulation and antibacterial activity evaluation Pharmazie 62 287 290
14. N Durán MA Alvarenga EC Da Silva PS Melo PD Marcato 2008 Microencapsulation of antibiotic rifampicin in poly(3-hydroxybutyrate-co-3- hydroxyvalerate) Arch Pharmacal Res 31 1509 1516 10.1007/s12272-001-2137-7
15. CV Ferreira CL Bos HH Versteeg GZ Justo N Durán MP Peppelenbosch 2004 Molecular mechanism of violacein-mediated human leukemia cell death Blood 104 1459 1464 1:CAS:528:DC%2BD2cXnt1ers78%3D 10.1182/blood-2004-02-0594
16. IF Gimenez MC Anazetti PS Melo M Haun MMM De Azevedo N Durán OL Alves 2005 Cytotoxicity on V79 and HL60 cell lines by thiolated-β- cyclodextrin-Au/violacein nanoparticles J Biomed Nanotechnol 1 352 358 1:CAS:528:DC%2BD2MXhtFyhsbnN 10.1166/jbn.2005.041
17. YE Har-el Y Kato 2007 Intracellular delivery of nanocarriers for cancer therapy Curr Nanosci 3 329 338 1:CAS:528:DC%2BD1cXhtlegtbs%3D 10.2174/157341307782418612
18. KK Jain 2008 Recent advances in nanooncology Technol Cancer Res Treat 7 1 13 1:CAS:528:DC%2BD1cXivFKgtLs%3D
19. LL Kodach CL Bos N Durán MP Peppelenbosch CV Ferreira JC Hardwick 2006 Violacein synergistically increases 5-fluorouracil cytotoxicity, induces apoptosis and inhibits Akt-mediated signal transduction in human colorectal cancer cells Carcinogenesis 27 508 516 1:CAS:528:DC%2BD28XhvVelu74%3D 10.1093/carcin/bgi307
20. M Kuroda T Ohta I Uchiyama T Baba H Yuzawa I Kobayashi L Cui A Oguchi K Aoki Y Nagai J Lian T Ito M Kanamori H Matsumaru A Maruyama H Murakami A Hosoyama Y Mizutani-Ui NK Takahashi T Sawano R Inoue C Kaito K Sekimizu H Hirakawa S Kuhara S Goto J Yabuzaki M Kanehisa A Yamashita K Oshima K Furuya C Yoshino T Shiba M Hattori N Ogasawara H Hayashi K Hiramatsu 2001 Whole genome sequencing of meticillin-resistant Staphylococcus aureus Lancet 357 9264 1225 1240 1:CAS:528:DC%2BD3MXjvVClur0%3D 10.1016/S0140-6736(00)04403-2
21. SCP Lopes C Yara GZ Justo PA Nogueira FLS Rodrigues U Goelnitz G Wunderlich G Facchini M Brocchi N Durán FTM Costa 2009 Violacein extracted from Chromobacterium violaceum inhibits Plasmodium growth in vitro and in vivo Antimicrob Agents Chemother 53 2149 2152 1:CAS:528:DC%2BD1MXlvVGnsro%3D 10.1128/AAC.00693-08
22. PD Marcato N Durán 2008 New aspects of nanopharmaceutical delivery systems J Nanosci Nanotechnol 8 2216 2229 1:CAS:528:DC%2BD1cXmslWrtbs%3D 10.1166/jnn.2008.274
23. M McClelland KE Sanderson J Spieth SW Clifton P Latreille L Courtney S Porwollik J Ali M Dante F Du S Hou D Layman S Leonard C Nguyen K Scott A Holmes N Grewal E Mulvaney E Ryan H Sun L Florea W Miller T Stoneking M Nhan R Waterston RK Wilson 2001 Complete genome sequence of Salmonella enterica serovar Typhimurium LT2 Nature 413 6858 852 856 1:CAS:528:DC%2BD3MXotFyrtL4%3D 10.1038/35101614
24. PS Melo MMM De Azevedo L Frungillo MC Anazetti PD Marcato PD Marcato N Durán 2009 Nanocytotoxicity: violacein and violacein-loaded poly(d,l-lactide-co-glycolide) nanoparticles acting on human leukemic cells J Biomed Nanotechnol 5 192 201 1:CAS:528:DC%2BD1MXksFWrtbg%3D 10.1166/jbn.2009. 1018
25. VC Mosqueira P Legrand H Pinto-Alphandary F Puisieux G Barratt 2000 Poly(d, l-lactide) nanocapsules prepared by a solvent displacement process: influence of the composition on physicochemical and structural properties J Pharm Sci 89 614 626 1:CAS:528:DC%2BD3cXjtlOitrk%3D 10.1002/(SICI)1520- 6017(200005)89:5<614::AID-JPS7>3.0.CO;2-7
26. CK Murray 2008 Infectious disease complications of combat-related injuries Crit Care Med 36 S358 S364 10.1097/CCM.0b013e31817e2ffc
27. LS Nair CT Laurencin 2007 Biodegradable polymers as biomaterials Prog Polym Sci 32 762 798 1:CAS:528:DC%2BD2sXovFeksL0%3D 10.1016/j.progpolymsci.2007. 05.017
28. JP Powell RP Wenzel 2008 Antibiotic options for treating community-acquired MRSA Expert Rev Anti Infect Ther 6 299 307 1:CAS:528:DC%2BD1cXmt1egtLo%3D 10.1586/14787210.6.3.299
29. D Rettori N Durán 1998 Production, extraction and purification of violacein: an antibiotic pigment produced by Chromobacterium violaceum World J Microbiol Biotechnol 14 685 688 1:CAS:528:DyaK1MXmtVygsQ%3D%3D 10.1023/A:1008809504504
30. SR Schaffazick SSU Guterres LD Freitas AR Polhmann 2003 Physicochemical characterization and stability of the polymeric nanoparticle systems for drug administration Quimica Nova 26 726 737 1:CAS:528:DC%2BD3sXns1Slsrk%3D
31. DM Sievert JT Rudrik JB Patel LC McDonald MJ Wilkins JC Hageman 2008 Vancomycin-resistant Staphylococcus aureus in the United States 2002-2006 Clin Infect Dis 46 668 674 1:CAS:528:DC%2BD1cXjslWgsbs%3D 10.1086/527392
32. MJ Soares LA Teixeira MR Nunes MC da Silva Carvalho BT Ferreira-Carvalho AM Figueiredo 2001 Analysis of different molecular methods for typing methicillin-resistant Staphylococcus aureus isolates belonging to the Brazilian epidemic clone J Med Microbiol 50 732 742 1:CAS:528:DC%2BD3MXlvVKjsro%3D
33. WHO-World Health Organization (2008) available at www.who.org. Accessed 23 Aug 2008
34. YQ Zhang SX Ren HL Li YX Wang G Fu J Yang ZQ Qin YG Miao WY Wang RS Chen Y Shen Z Chen ZH Yuan GP Zhao D Qu A Danchin YM Wen 2003 Genome-based analysis of virulence genes in a non-biofilm-forming Staphylococcus epidermidis strain (ATCC 12228) Mol Microbiol 49 1577 1593 1:CAS:528:DC%2BD3sXnslKit7c%3D 10.1046/j.1365-2958.2003.03671.x